Addyi is the only FDA-approved pill proven effective for the treatment of HSDD (Hypoactive Sexual Desire Disorder) in certain premenopausal women. In clinical trials, Addyi demonstrated improvement in desire, a reduction in distress and an increase in satisfying sexual events. With more than 10 million pills prescribed, Addyi is a top treatment for HSDD, or frustrating low libido. Learn about Addyi's new direct dispense program, as well as important safety and prescribing information, at addyihcp.com.